Cargando…

Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription

Intrinsic antiviral host factors confer cellular defense by limiting virus replication and are often counteracted by viral countermeasures. We reasoned that host factors that inhibit viral gene expression could be identified by determining proteins bound to viral DNA (vDNA) in the absence of key vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eui Tae, Dybas, Joseph M., Kulej, Katarzyna, Reyes, Emigdio D., Price, Alexander M., Akhtar, Lisa N., Orr, Ann, Garcia, Benjamin A., Boutell, Chris, Weitzman, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856100/
https://www.ncbi.nlm.nih.gov/pubmed/33432153
http://dx.doi.org/10.1038/s41564-020-00826-3
_version_ 1783646217267314688
author Kim, Eui Tae
Dybas, Joseph M.
Kulej, Katarzyna
Reyes, Emigdio D.
Price, Alexander M.
Akhtar, Lisa N.
Orr, Ann
Garcia, Benjamin A.
Boutell, Chris
Weitzman, Matthew D.
author_facet Kim, Eui Tae
Dybas, Joseph M.
Kulej, Katarzyna
Reyes, Emigdio D.
Price, Alexander M.
Akhtar, Lisa N.
Orr, Ann
Garcia, Benjamin A.
Boutell, Chris
Weitzman, Matthew D.
author_sort Kim, Eui Tae
collection PubMed
description Intrinsic antiviral host factors confer cellular defense by limiting virus replication and are often counteracted by viral countermeasures. We reasoned that host factors that inhibit viral gene expression could be identified by determining proteins bound to viral DNA (vDNA) in the absence of key viral antagonists. Herpes simplex virus 1 (HSV-1) expresses ICP0, which functions as an E3 ubiquitin ligase required to promote infection. Cellular substrates of ICP0 have been discovered as host barriers to infection, but mechanisms for inhibition of viral gene expression are not fully understood. To identify restriction factors antagonized by ICP0, we compared proteomes associated with vDNA during HSV-1 infection with wild-type (WT) virus and mutant lacking functional ICP0 (ΔICP0). We identified the cellular protein Schlafen 5 (SLFN5) as an ICP0 target that binds vDNA during HSV-1 ΔICP0 infection. We demonstrated that ICP0 mediates ubiquitination of SLFN5 which leads to its proteasomal degradation. In the absence of ICP0, SLFN5 binds vDNA to repress HSV-1 transcription by limiting accessibility of RNA polymerase II to viral promoters. These results highlight how comparative proteomics of proteins associated with viral genomes can identify host restriction factors, and reveal that viral countermeasure can overcome SLFN antiviral activity.
format Online
Article
Text
id pubmed-7856100
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-78561002021-07-11 Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription Kim, Eui Tae Dybas, Joseph M. Kulej, Katarzyna Reyes, Emigdio D. Price, Alexander M. Akhtar, Lisa N. Orr, Ann Garcia, Benjamin A. Boutell, Chris Weitzman, Matthew D. Nat Microbiol Article Intrinsic antiviral host factors confer cellular defense by limiting virus replication and are often counteracted by viral countermeasures. We reasoned that host factors that inhibit viral gene expression could be identified by determining proteins bound to viral DNA (vDNA) in the absence of key viral antagonists. Herpes simplex virus 1 (HSV-1) expresses ICP0, which functions as an E3 ubiquitin ligase required to promote infection. Cellular substrates of ICP0 have been discovered as host barriers to infection, but mechanisms for inhibition of viral gene expression are not fully understood. To identify restriction factors antagonized by ICP0, we compared proteomes associated with vDNA during HSV-1 infection with wild-type (WT) virus and mutant lacking functional ICP0 (ΔICP0). We identified the cellular protein Schlafen 5 (SLFN5) as an ICP0 target that binds vDNA during HSV-1 ΔICP0 infection. We demonstrated that ICP0 mediates ubiquitination of SLFN5 which leads to its proteasomal degradation. In the absence of ICP0, SLFN5 binds vDNA to repress HSV-1 transcription by limiting accessibility of RNA polymerase II to viral promoters. These results highlight how comparative proteomics of proteins associated with viral genomes can identify host restriction factors, and reveal that viral countermeasure can overcome SLFN antiviral activity. 2021-01-11 2021-02 /pmc/articles/PMC7856100/ /pubmed/33432153 http://dx.doi.org/10.1038/s41564-020-00826-3 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Kim, Eui Tae
Dybas, Joseph M.
Kulej, Katarzyna
Reyes, Emigdio D.
Price, Alexander M.
Akhtar, Lisa N.
Orr, Ann
Garcia, Benjamin A.
Boutell, Chris
Weitzman, Matthew D.
Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription
title Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription
title_full Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription
title_fullStr Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription
title_full_unstemmed Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription
title_short Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription
title_sort comparative proteomics identifies schlafen 5 (slfn5) as a herpes simplex virus restriction factor that suppresses viral transcription
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856100/
https://www.ncbi.nlm.nih.gov/pubmed/33432153
http://dx.doi.org/10.1038/s41564-020-00826-3
work_keys_str_mv AT kimeuitae comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT dybasjosephm comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT kulejkatarzyna comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT reyesemigdiod comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT pricealexanderm comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT akhtarlisan comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT orrann comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT garciabenjamina comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT boutellchris comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription
AT weitzmanmatthewd comparativeproteomicsidentifiesschlafen5slfn5asaherpessimplexvirusrestrictionfactorthatsuppressesviraltranscription